AR and Familial prostate cancer: This was demonstrated in a recent study of advanced prostate cancer integrating WGS, whole transcriptome, and ChIP-Seq data that showed tandem duplications involving non-coding regulatory regions are significantly associated with the expression of the androgen receptor (AR), a key driver of prostate cancer progression and metastasis4,5.